GILEAD SCIENCES, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Gilead Sciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q3 2024.
  • Gilead Sciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $306M.
  • Gilead Sciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $334M.
  • Gilead Sciences, Inc. annual Nonoperating Income (Expense) for 2023 was $198M.
  • Gilead Sciences, Inc. annual Nonoperating Income (Expense) for 2022 was -$581M, a 9.08% increase from 2021.
  • Gilead Sciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$639M, a 54.9% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $334M $306M +$378M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$44M -$355M -$507M -334% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $463M $91M +$265M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $198M $292M +$302M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 -$104M -$72M +$104M +59.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$208M $152M +$436M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$644M -$174M -$63M -56.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$581M -$10M -$67M -118% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 -$514M -$176M -$22M -14.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$492M -$284M -$111M -64.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$381M -$111M +$258M +69.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$639M $57M +$627M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 -$1.27B -$154M +$786M +83.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$2.05B -$173M -$423M -169% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$1.63B -$369M -$211M -134% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$1.42B -$570M -$1.62B -154% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $203M -$940M -$1.16B -523% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $1.37B $250M +$22M +9.65% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.34B -$158M -$525M -143% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.87B $1.05B +$922M +715% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $946M $222M -$83M -27.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $1.03B $228M +$156M +217% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $873M $367M +$197M +116% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $676M $129M -$3M -2.27% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $679M $305M +$155M +103% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $524M $72M -$58M -44.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $582M $170M +$59M +53.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $523M $132M -$8M -5.71% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $531M $150M +$31M +26.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $500M $130M +$42M +47.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $458M $111M +$30M +37% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $428M $140M +$94M +204% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $334M $119M +$67M +129% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $267M $88M +$53M +151% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $214M $81M +$60M +286% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $154M $46M +$16M +53.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $138M $52M +$57M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $81M $35M +$39M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $42M $21M +$39M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $3M $30M +$41.2M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 -$38.2M -$5M -$10.8M -187% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$27.4M -$4M -$3.77M -1632% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$23.7M -$18M -$14.7M -442% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$9M -$11.2M -$12.9M -774% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-24
Q3 2013 $3.89M $5.78M +$9.28M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$5.4M -$231K +$844K +78.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 -$6.24M -$3.32M +$30.8M +90.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$37M $1.67M -$24.7M -93.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 -$12.3M -$3.51M -$17.9M -124% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 $5.61M -$1.08M -$13.1M -109% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $18.7M -$34.1M -$47.9M -346% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $66.6M $26.4M +$15.6M +145% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $51M $14.4M -$1.19M -7.61% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $52.2M $12M -$6.31M -34.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 $58.5M $13.8M -$1.81M -11.6% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $60.3M $10.8M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $15.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $18.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 $15.6M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.